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Label-free discrimination analysis of de-diﬀerentiated vascular smooth
muscle cells, mesenchymal stem cells and their vascular and osteogenic
progeny using vibrational spectroscopy
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The accumulation of vascular smooth muscle (SMC)-like cells and stem cell-derived myogenic and osteogenic
progeny contributes signiﬁcantly to arteriosclerotic disease. This study established whether label-free vibrational
spectroscopy can discriminate de-diﬀerentiated ‘synthetic’ SMCs from undiﬀerentiated stem cells and their
myogenic and osteogenic progeny in vitro, compared with conventional immunocytochemical and genetic
analyses. TGF-β1- and Jagged1-induced myogenic diﬀerentiation of CD44+ mesenchymal stem cells was conﬁrmed in vitro by immunocytochemical analysis of speciﬁc SMC diﬀerentiation marker expression (α-actin,
calponin and myosin heavy chain 11), an epigenetic histone mark (H3K4me2) at the myosin heavy chain 11
locus, promoter transactivation and mRNA transcript levels. Osteogenic diﬀerentiation was conﬁrmed by alizarin red staining of calcium deposition. Fourier Transform Infrared (FTIR) maps facilitated initial screening and
discrimination while Raman spectroscopy of individual cell nuclei revealed speciﬁc spectral signatures of each
cell type in vitro, using Principal Components Analysis (PCA). PCA fed Linear Discriminant Analysis (LDA) enabled quantiﬁcation of this discrimination and the sensitivity and speciﬁcity value was determined for all cell
populations based on a leave-one-out cross validation method and revealed that de-diﬀerentiated SMCs and
stem-cell derived myogenic progeny in culture shared the greatest similarity. FTIR and Raman spectroscopy
discriminated undiﬀerentiated stem cells from both their myogenic and osteogenic progeny. The ability to detect
stem cell-derived myogenic progeny using label-free platforms in situ may facilitate interrogation of these important phenotypes during vascular disease progression.

1. Introduction
Cardiovascular diseases (CVD), such as arteriosclerosis, in-stent
restenosis and pulmonary hypertension (PAH), remain a leading cause
of global death and result from pathologic arterial remodelling [1,2]. A
hallmark of arterial remodelling is intimal medial thickening (IMT) due
to the accumulation of vascular smooth muscle (SMC)-like cells within
the intima leading to the obstruction of blood ﬂow and resulting in a
heart attack or stroke [3]. The source of these neointimal cells includes
stem cell-derived myogenic progeny (St-SMCs) [4–7] and SMCs following endothelial-mesenchymal transition (EndMT) [4,8] in addition
to de-diﬀerentiation and reprogramming of SMCs (ddSMCs) [9].
Transforming growth factor (TGF)-β1 and Notch ligands (Jagged1) are

⁎
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both putative regulators of stem cell myogenic diﬀerentiation in vitro
[10,11] and may contribute to stem cell myogenic diﬀerentiation and
SMC accumulation during arterial remodelling in vivo [6,12,13].
Therefore, early detection of de-diﬀerentiated SMCs and/or stem cellderived progeny (following myogenic diﬀerentiation) by these factors
as a source of neointimal cells during early stages of disease and its
progression by means a novel photonic interrogation system would be
highly desirable.
Amongst the various imaging platforms available to interrogate
closely related cell populations and discriminate cell-dependent
changes in vessel structure due to arteriosclerosis, label-free techniques
such as vibrational spectroscopy have shown great promise [14]. Vibrational spectroscopy is a subset of spectroscopy which analyses
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Olympus CK30 microscope with Cell^F software was used to capture
images. At least ﬁve images from the Olympus CK30 microscopy per
experimental group (minimum n = 3) were analysed using ImageJ
software as previously described [20,21].

vibrations within a molecule (or material), which are characteristic of
the molecular structure and, in polyatomic molecules, give rise to a
spectroscopic “ﬁngerprint” of that molecule. The spectrum of vibrational energies can thus be employed to characterise a molecular
structure, or changes to it due to the local environment or external
factors (e.g. radiation, chemical agents). Vibrational energies fall within
the mid - Infrared (IR) region of the electromagnetic spectrum and are
commonly probed through IR absorption spectroscopy [15]. Raman
spectroscopy is a complementary technique whereby incident radiation
couples with the oscillating polarisation of the molecule and thus
generates or annihilates a vibrational quantum, similarly resulting in a
vibrational spectrum [16]. The diﬀering underlying mechanisms give
rise to a complementarity of the two techniques, such that vibrations of
asymmetric, polar bonds tend to be strong in IR spectra, whereas
Raman is particularly suitable as a probe of symmetric, nonpolar
groups. Moreover, FTIR monitors the absorption of IR radiation
whereas Raman scattering can be employed in the UV, visible or nearIR regions of the spectrum and thus oﬀers intrinsically higher spatial
resolution for cellular and subcellular mapping or proﬁling. The limit of
resolution is determined classically by the wavelength (< 1 μm for
Raman, ~ 5-10 μm for IR) [17]. Therefore, the longer wavelength of
mid infrared radiation, coupled with the use of multidetector arrays in
the Fourier Transform mode, render IR techniques more suitable for
mapping larger cell populations or tissue sections [18].
The current study was undertaken to establish whether vibrational
spectroscopy could be implemented as a novel photonic platform to
discriminate undiﬀerentiated bone marrow-derived stem cells from
their myogenic progeny following diﬀerentiation in vitro and further
whether these cell populations could be discriminated from de-diﬀerentiated ‘synthetic’ SMCs and stem cell-derived osteogenic progeny.

2.4. Realtime qRT-PCR
Quantitative real-time RT-PCR was performed using the Rotor Gene
(RG-3000, Corbett Research) and a Quantitect™ Primer assay system
using Quantitect rat primers (Qiagen, Manchester UK) as previously
described [20]. Gene expression was normalised to that of the housekeeping gene, hypoxanthine-guanine phosphoribosyltransferase
(HPRT).
2.5. Chromatin immunoprecipitation assay (ChIP assay)
Cells were cross-linked and DNA was sheared to 500–1000 bp by
sonication before ChIP analysis was carried out using the MAGnify™
Chromatin Immunoprecipitation System (InVitrogen, Bioscience
Ireland, cat no 49-2024) according to the manufacturer's instruction.
Recovered DNA was analysed by qPCR. The ChIP-qPCR data was normalised for sources of variability, including amount of chromatin, efﬁciency of immunoprecipitation, and DNA recovery using the Fold
Enrichment Method. This normalisation method is also called ‘signal
over background’ or ‘relative to the no-antibody control’. With this
method, the ChIP signals are divided by the no-antibody signals, representing the ChIP signal as the fold increase in signal relative to the
background signal. The assumption of this method is that the level of
background signal is reproducible between diﬀerent primer sets, samples, and replicate experiments. All samples were performed in triplicate from at least three independent experiments.

2. Methods
2.6. Myh11-promoter luciferase assay
2.1. Materials
Cells were transiently transfected with Myh11 reporter plasmid
(Myh11-GLuc, GeneCopoeia, Inc. Cat No; MPRM16957-PG02) and
Renilla reporter plasmid (Promega, Madison, WI) for 24 h using
TransIT-X2® Dynamic Delivery System (Mirus Bio, Madison, WI) in
OptiMEM according to the manufacturer's instruction. Gaussia luciferase activities were normalised to the activity of internal control
Renilla luciferase activities using the dual luciferase assay system described by the manufacturer (Promega, Madison, WI). All assays were
performed in triplicate.

Unless otherwise stated, all chemicals and reagents were obtained
from Sigma-Aldrich and were of the highest purity commercially
available (Sigma-Aldrich, Ireland). A more detailed version of the
Methods is presented in the Appendix A.
2.2. Cell culture
Freshly isolated vascular SMC were grown up to passage 4 in culture
in RPMI-1640 supplemented with 10% FCS, as previously described
[19] and were deemed proliferative de-diﬀerentiated “synthetic” SMCs
(ddSMCs). Sprague-Dawley rat mesenchymal stem cells (bm-MSC) were
purchased from Gibco (S1601-100) and cultured as per the manufacturer's instructions. These rat bm-MSCs have been validated previously
as multipotent stem cells that have a large capacity for self-renewal
while maintaining their multipotency [20,21]. Importantly, this cell
population expresses all the common MSC markers and is able to differentiate into the three lineages recapitulating a ‘true’ mesenchymal
cell phenotype http://tools.thermoﬁsher.com/content/sfs/manuals/
GIBCO_Rat_(SD)_MSCs.pdf). Myogenic and osteogenic diﬀerentiation
of bm-MSC was established following culture of cells in DMEM supplemented with TGF-β1 (R&D, 7666-MB-005) (St-SMC-TGF-β1), recombinant Jagged1-Fc (R&D, 599-JG) (St-SMC-Jag-1) for 14 days and
StemPro® Osteogenic Diﬀerentiation Kit (ThermoFisher, USA,
A1007201) for 21 days, respectively.

2.7. Sample preparation for spectroscopic analysis
For both FTIR and Raman spectroscopic analyses, cells were seeded
on calcium ﬂuoride slides in 6 well plates at approximately 10,000
cells/well. After ﬁxation, the slides were washed with PBS and placed
brieﬂy in distilled water. The slides were left to air dry before recording
spectra.
2.8. FTIR spectroscopy
IR absorption measurements were carried out using a Perkin Elmer
Spotlight 400 N FTIR imaging system. The system was equipped with
an AutoImage microscope system operating with a × 40 Cassegrain
objective and operates in transmission or reﬂection mode. FTIR images
were acquired in transmission mode with 10 scans of a 150 × 150 μm
area of the slide for each cell population. All experiments were carried
out in triplicate (576 spectra per scan were recorded, 30 scans per
sample, ~ 15,000 spectra per cell population). Individual spectra were
acquired with a liquid nitrogen cooled mercury cadmium telluride
(MCT-A) line detector of pixel size 6.25 μm × 6.25 μm at a spectral
resolution of 4 cm− 1, interferometer speed of 1.0 cm/s and the useable
spectral range is restricted to 900–4000 cm− 1. Background

2.3. Immunocytochemistry
Fixed cells were incubated overnight at 4 °C with primary antibodies at the appropriate dilution washed and further incubated with
the secondary antibody (Biosciences, anti-goat A-11055, anti-rabbit
A11008) at a dilution of 1:1000 for 1 h at room temperature. An
344
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measurements were acquired on a region with no cells with 120 scans per pixel whereas 32 scans per pixel were recorded from the sample.
2.9. Raman spectroscopy
Raman spectra were recorded using a custom-built Raman microspectroscopy system, as previously described [22,23]. Brieﬂy, this
system employed a 150 mW laser with a wavelength of 532 nm (Laser
Quantum, Torus), spectrograph (Andor, Shamrock 500) operating with
600 lines/mm grating, and a CCD camera (Andor; DU420A-BR-DD)
cooled to − 80 °C. A 50× microscope objective (MO), with numerical
aperture of 0.8 (Olympus, UMPlanFl), was used to image the spectral
irradiance to a 100 μm confocal aperture, which isolates the signal from
the cell nucleus, and minimises background noise from the sample
substrate, as well as from optical elements in the system [22,23].
2.10. Data processing and analysis
The diﬀerent data pre-processing and analysis steps were performed
using Matlab (Mathworks, USA). For FTIR data, the resonant Mie
scattering correction algorithm (RMieS-EMSC) was employed to remove scattering eﬀects from FTIR spectra [24], as has been successfully
demonstrated in a number of studies [25]. For Raman data, cosmic ray
removal is followed by application of an extended multiplicative signal
correction (EMSC) algorithm as described in detail previously [23].
After pre-processing, Principal Components Analysis (PCA) was employed as an unsupervised multivariate analysis tool to diﬀerentiate the
data recorded from diﬀerent cell phenotypes.

Fig. 1. (a). Representative mean FTIR spectra recorded for bm-MSCs following Resonant
Mie (RMieS) correction with classiﬁcation of relevant peaks and their known association
to proteins, nucleic acid and lipids described in Table 1. (b) Processed mean Raman
spectra for bm-MSCs following cosmic ray removal and EMSC correction and their known
association to proteins, nucleic acid and lipids are described in Table 2.

2.11. Statistical analysis
Table 1
Peak assignments for FTIR spectra data.

All biochemical analysis experiments were performed in triplicate
and data are presented as mean ± SEM for at least three independent
runs. Statistical analysis was performed with Prism v6 software package
using t-test for parametric data or a Wilcoxon Signed Rank test for nonparametric data.
3. Results
3.1. FTIR and Raman spectroscopy both discriminate bone-marrow derived
mesenchymal stem cells from their osteogenic progeny in vitro
A sample population of CD44+ bm-MSCs was analysed by both FTIR
and Raman spectroscopy, and the raw spectra recorded, processed and
the mean spectrum presented [Fig. 1]. The FTIR bands are labelled with
assignments of typical biochemical origin. In the “high wavenumber
region”, > 2500 cm− 1, the distinctive vibrations of NeH, CeH and
OeH of lipids and proteins can be found, whereas in the “ﬁngerprint
region”, < 2000 cm− 1, the features are typically more complex combinations, including the Amide I (1650 cm− 1) and Amide II
(1520 cm− 1) modes of proteins, nucleic acid phosphate stretching
modes at 1070 cm− 1 and 1250 cm− 1 and lipidic derived features at
1310 cm− 1 and 1750 cm− 1. A more detailed list of band assignments is
provided in Table 1. Mean Raman spectra for bm-MSC nuclei were also
recorded and analysed following cosmic ray removal and EMSC correction. The prominent peaks in bm-MSCs are annotated and presented
in Fig. 1(b), Table 2. It should be noted that, although complementary
techniques, the features in the respective spectra of FTIR and Raman
have similar origin. Thus, the Raman spectrum of the nucleus exhibits
similarly prominent signatures associated with proteins and lipids
across the ﬁngerprint region, as well as large peaks related to DNA and
RNA at 785 cm− 1.
Osteogenic diﬀerentiation of bm-MSC to osteogenic progeny (StOsteo) was ﬁrst validated by phase contrast microscopy of gross morphological diﬀerences before and after osteogenic diﬀerentiation. StOsteo cells were morphologically distinct from bm-MSC and exhibited a

Wavenumber

FTIR peak assignments

Association

(i)
(ii)
(iii)
(iv)

1036
1072
1152
1220–1280

Proteins
DNA/RNA
Proteins
DNA/RNA

(v)
(vi)
(vii)
(viii)
(ix)
(x)
(xi)
(xii)

1312
1400
1456
1546
1620–1700
1742
2854
2926

CeC skeletal stretching
PO2 symmetric stretching
CeC and CeO stretching
PO2 asymmetric stretching
Amide III
CH2 stretching
CH3 symmetric stretching
CH3 asymmetric stretching
Amide II
Amide I
Ester, C]O stretching
CH2 symmetric stretching
CH2 asymmetric stretching

Phospholipids
Proteins
Proteins
Proteins
Proteins
Lipids
Lipids
Lipids

more osteoblast phenotype with a pronounced, large spherical nucleus
[Fig. 2a(ii–iii)]. Alizarin red staining conﬁrmed the presence of calcium
deposits in St-Osteo when compared to bm-MSC [Fig. 2a(iv–v)], providing evidence for bm-MSC multipotency in vitro. Osteogenic diﬀerentiation of bm-MSC to St-Osteo was analysed by FTIR spectroscopy
and a spectrally integrated IR map of a representative population of bmMSC is presented [Fig. 2a(vi)]. There were notable diﬀerences in the StOsteo mean spectra across the high wavenumber (2000-3500 cm− 1)
and ﬁngerprint (1000–1800 cm− 1) regions [Fig. 2b], in particular, a
strong feature at ~1037 cm− 1 that overlapped the nucleic acid phosphate backbone band at ~1070 cm− 1 that is commonly assigned to
carbonate groups in apatite [26]. There were also notable diﬀerences at
2964 cm− 1 (corresponding to CH3 asymmetric stretching of lipids and
proteins) where St-Osteo cells had a greater peak intensity. The loading
of the discriminating PC1 demonstrated pronounced increases in the
feature at 1037 cm− 1 for St-Osteo and a reduction of the strong Amide I
and Amide III features at 1220–1280 cm− 1 [Fig. 2b]. PCA identiﬁed all
signiﬁcant changes across the FTIR spectroscopic datasets and the
scatter plots generated clearly discriminated both groups from each
345
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48 h [Fig. 3e] concomitant with a dramatic increase in the number of
smooth muscle cell α-actin (SMA+) and CNN1+ positive cells after 7 d
[Fig. 3f].
FTIR maps and mean spectra were recorded for bm-MSC and their
myogenic progeny [Fig. 3g]. In both cases, there were signiﬁcant peak
intensity diﬀerences in myogenic progeny in the high wavenumber
region, > 2500 cm− 1, in particular, between 2800 cm− 1 and
3000 cm− 1 [Fig. 3 g] which is associated with acyl chain stretching
vibrations from fatty acids of lipids [30]. There were also signiﬁcant
spectral diﬀerences in bands in the CeH stretching region associated
with absorbance from lipids (3050-2800 cm− 1), the amide I and II region associated with protein absorbance (1700–1500 cm− 1), and in the
lower wavenumber region associated with nucleic acids
(1300–1000 cm− 1) [Fig. 3g]. Notably, PCA of the FTIR spectroscopic
data demonstrated that bm-MSCs could be clearly separated from their
myogenic progeny according to the ﬁrst principal component (PC1)
[Fig. 3h]. Moreover, 3-way multivariate statistical analysis revealed
that bm-MSC could be clearly discriminated from their myogenic progeny, independent of the inductive stimulus to generate the progeny
[Fig. 3h].

Table 2
Peak assignments for Raman spectra data.
Wavenumber

Chemical bond

Association

(i)

785–788

Nucleic acid

(ii)
(iii)

1004
1090

(iv)

1127

(v)

1262

(vi)

1319

(vii)

1341

(viii)
(ix)
(x)
(xi)

1451
1585
1619
1662

Stretching of DNA related bonds, and
DNA/RNA breathing modes
Phenylalanine
Stretching of DNA related bonds
Stretching of CeN backbone
Stretching of CeN backbone
Stretching of CeC
DNA/RNA breathing modes
Amide III
CH2, CH3 twisting
DNA/RNA breathing modes
CH deformation vibration
DNA/RNA breathing modes
CH deformation vibration
CH2 deformation vibration
DNA/RNA breathing modes
Tyrosine; tryptophan
DNA/RNA breathing modes
Amide I
Fatty acids

Protein
Nucleic acid
Protein
Protein
Lipid
Nucleic acid
Lipid
Lipid
Nucleic acid
Protein
Nucleic acid
Protein
Protein/lipid
Nucleic acid
Protein
Nucleic acid
Protein
Lipid

3.3. FTIR spectroscopic comparisons between de-diﬀerentiated SMC, MSCs
and stem cell derived myogenic progeny

other [Fig. 2c].
Raman spectra of individual cell nuclei from bm-MSC and St-Osteo
were also recorded and the mean spectra are superimposed to reveal
clear diﬀerences [Fig. 2d]. The most pronounced was the peak at
960 cm− 1, clearly indicating the presence of phosphates associated
with mineralisation within the St-Osteo cells [Fig. 2d] [27]. Prominent
bands at 1030 cm− 1 and 1070 cm− 1 associated with phosphate and
carbonate groups respectively, were also evident although they were
very much weaker compared to the prominent 960 cm− 1 feature.
Several other peaks were observed that clearly separated bm-MSC from
their osteogenic progeny and relate to nucleic acid (DNA/RNA) at
788 cm− 1, 1338 cm− 1, 1490 cm− 1, and 1585 cm− 1 as well as lipids at
1379 cm− 1 [Fig. 2d]. PCA identiﬁed signiﬁcant changes across the
spectrum and the scatter plots generated clearly discriminated both
groups from each other [Fig. 2e].

Morphological analysis of dissociated rat aortic SMC grown in culture up to passage 4 (ddSMCs) exhibited strong cytoplasmic refractivity, an oval nucleus and rich cytoplasm and overlapped when
conﬂuent, forming typical SMC ‘peak-to-valley’ growth, as previously
reported [31]. The two major morphological phenotypes were ‘spindle
shaped’ and ‘epithelioid’ [Fig. 4a]. In contrast, the majority of myogenic
progeny [St-SMC-TGF-β1] were spindle-like cells without a strong cytoplasmic refractivity [Fig. 4a]. The levels of SMA and Myh11 protein
and Myh11 mRNA transcripts were signiﬁcantly reduced in ddSMC
when compared to freshly isolated rat aortic SMCs and were comparable to the levels present in stem cell-derived myogenic progeny [StSMC-TGF-β1] [Fig. 4b, c].
FTIR maps and mean spectra were recorded and analysed for
ddSMCs and compared to both undiﬀerentiated bm-MSCs and their
myogenic (St-SMC-TGF-β1) and osteogenic progeny (St-Osteo), respectively [Fig. 4d], before PCA analysis of the spectroscopic datasets
was performed [Fig. 4e]. Prominent peaks were observed for ddSMCs
across the high wavenumber (2000-3500 cm− 1) and ﬁngerprint (10001800 cm− 1) regions of the spectrum. In particular, the main spectral
characteristics were bands at ~1540 cm− 1 and 1650 cm− 1 (amide I
and II, respectively), ~1060 cm− 1, 1225 cm− 1 and 1460 cm− 1 (CeC
and CeH bending) and ~2850 cm− 1–2960 cm− 1 and 3325 cm− 1. The
peak at ~1225 cm− 1, associated with phosphate stretching modes, was
noticeably reduced in both ddSMC and St-Osteo cells, when compared
undiﬀerentiated bm-MSC and their myogenic progeny [Fig. 4d], respectively, as were the peaks at 1380 cm− 1 and 1660 cm− 1 (associated
with amide I and II proteins) and 2850–2960 cm− 1 (associated with
distinctive vibrations of NeH, CeH and OeH of lipids and proteins)
[Fig. 4d]. In contrast, the ddSMC had a more prominent peak at the
~1036 cm− 1 and ddSMC and St-Osteo cells at ~3296 cm− 1 that are
associated with proteins [Table 1 [Fig. 4d].
Using 4-way multivariate statistical analysis, there was a signiﬁcant
separation of the four populations by FTIR [Fig. 4e, Table 3] as it
successfully discriminated ddSMCs, undiﬀerentiated bm-MSCs and
their myogenic (St-SMC-TGF-β1) or osteogenic (St-Osteo) progeny.
Moreover, using PCA/LDA, FTIR could discriminate between undiﬀerentiated bm-MSCs from both their myogenic and osteogenic progeny (St-Osteo) with signiﬁcant conﬁdence even when these daughter
cells originated from the same undiﬀerentiated bm-MSC stem cell population [Table 3].

3.2. FTIR and Raman spectroscopy discriminates bone-marrow derived
mesenchymal stem cells from their myogenic progeny in vitro
Myogenic diﬀerentiation following treatment of bm-MSC with TGFβ1 was conﬁrmed by determining the enrichment of a synonymous SMC
epigenetic histone signature at the myosin heavy chain 11 (Myh11)
promoter, Myh11 promoter transactivation, SMC diﬀerentiation marker
transcript levels (Myh11, CNN1) and immunocytochemical detection of
the number of Myh11 and CNN1 cells, respectively [Fig. 3]. Chromatin
immunoprecipitation (ChIP) analysis of freshly isolated rat aortic SMCs
conﬁrmed the enrichment of the speciﬁc SMC epigenetic mark, di-methylation of lysine 4 on histone H3 (H3K4me2) at the Myh11 locus [28]
concomitant with a lack of enrichment of the tri-methylation of lysine
27 on histone H3 (H3K27me3) mark which is consistent with a general
repression of developmental genes [29] [Fig. 3a]. In contrast, bm-MSC
were enriched for the H3K27me3 mark at the same locus [Fig. 3a].
Treatment of bm-MSC with TGF-β1 (2 ng/ml) for 7 d increased the level
of enrichment of the H3K4me2 mark with a reciprocal diminution of
the H3K27me3 mark to levels that were comparable to H3K4me2 and
H3K27me3 levels in sub-cultured de-diﬀerentiated rat SMCs (ddSMCs)
[Fig. 3a]. TGF-β1 treatment also signiﬁcantly induced Myh11-promoter
transactivation [Fig. 3b] after 2 d concomitant with enhanced Myh11
mRNA levels [Fig. 3c]. Furthermore, treatment of bm-MSCs with TGFβ1 (2 ng/ml) for 14 d resulted in a marked increase in the number of
Myh11+ and calponin-1 (CNN1+) positive cells, when compared to
vehicle control [Fig. 3d]. Similarly, treatment of bm-MSC with Jag-1-Fc
resulted in a signiﬁcant increase in Myh11 and CNN1 mRNA levels after
346
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Fig. 2. (a) (i) Representative immunocytochemical image of CD44+ bm-MSC in culture, (ii–iii) phase contrast images and (iv, v) alizarin red staining of bm-MSCs before and after
osteogenic diﬀerentiation with osteogenic inductive media for 21 d, (vi) representative FTIR heat map of bm-MSCs. (b) Mean FTIR spectra and loading plot of the ﬁrst principal
component and (c) PCA score plot of the bm-MSCs (black) and the St-Osteo (green) cell groups before and after osteogenic diﬀerentiation. (d) Mean Raman spectra and loading plot of the
ﬁrst principle component following PCA of the processed bm-MSC and St-Osteo datasets and (e) PCA score plot of bm-MSCs and St-Osteo before and after osteogenic diﬀerentiation.

osteogenic (St-Osteo) progeny with signiﬁcant conﬁdence even when
these daughter cells originated from the same undiﬀerentiated bm-MSC
stem cell population [Table 4].
When the Raman spectra for bm-MSC and their myogenic progeny
(St-SMC-TGF-β1) were compared [Fig. 5a], there was a clear separation
across both of the ﬁrst two components [Fig. 5b]. Analysis of the prominent spectral features in both PC1 and PC2 for these cells revealed
signiﬁcant spectral diﬀerences relating to nucleic acid (DNA/RNA) at
788 cm− 1, 1090 cm− 1, 1262 cm− 1, 1338 cm− 1, 1373 cm− 1,
1490 cm− 1, and 1581 cm− 1; proteins at 1004 cm− 1, 1053 cm− 1 and
1614–1619 cm− 1; and lipids at 1262 cm− 1, 1300 cm− 1, 1379 cm− 1,
1439–1454 cm− 1 and 1650 cm− 1–1695 cm− 1, respectively [Fig. 5a].
When the Raman spectra for ddSMC were compared to bm-MSC
[Fig. 5c], there was a clear separation across only the ﬁrst component

3.4. Raman spectroscopic comparisons between de-diﬀerentiated SMC,
MSCs and stem cell derived SMC progeny
All four cell populations were separated by multivariate statistical
analysis of Raman spectra [Fig. 4f] using a 4-way PCA scatterplot
[Fig. 4g, Table 4] with the most notable diﬀerences apparent for the StOsteo spectra [Fig. 4f]. Peak intensities were higher at the
785–788 cm− 1 and 1585 cm− 1 correlating to nucleic acids, 960 cm− 1
corresponding to its strong phosphate peak and the 1375 cm− 1 associated with proteoglycans [32]. Many other prominent wavenumbers in
the loadings for the ﬁrst two principal components are also highlighted
and the wavenumber associations are discussed below [Fig. 4f].
Using PCA/LDA, Raman spectroscopy discriminated undiﬀerentiated bm-MSCs from both their myogenic (St-SMC-TGF-β1) and
347
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Fig. 3. (a) Representative Chromatin Immunoprecipitation (ChIP) analysis of H3K4me and H4K27me3 enrichment at the Myh11 locus in freshly isolated diﬀerentiated aortic SMCs, subcultured ddSMCs and bm-MSCs before and after myogenic diﬀerentiation with TGF-β1 (2 ng/ml) for 7 d. Data are the mean ± SEM of three samples and are representative of 3 similar
experiments (b) Myh11 promoter transactivation and (c) Myh11 mRNA expression levels in bm-MSCs before and after myogenic diﬀerentiation with TGF-β1 (2 ng/ml) for 2 d. Data are
the mean ± SEM of three experiments (d) representative immunocytochemical analysis of the number of Myh11+ and CNN1+ cells before and after myogenic diﬀerentiation of bm-MSC
with TGF-β1 (2 ng/ml) for 7 d, (e) CNN1 and Myh11 mRNA levels before and after myogenic diﬀerentiation with Jagged1 (2 μg/ml) for 2 d and (f) representative immunocytochemical
analysis of the number of SMA+ and CNN1+ before and after myogenic diﬀerentiation with Jag-1 (100 ng/ml) for 5 d. (g) Mean FTIR spectra and (h) scatter plot of the ﬁrst principal
component after PCA for bm-MSCs before and after myogenic diﬀerentiation with TGF-β1 (2 ng/ml) and Jag-1 (2 μg/ml) for 14 d.

achieved using a combination of PCA and LDA when applied to each of
the four experimental groups. The ddSMC were classiﬁed correctly with
89.7% sensitivity and the St-SMC (TGF-β1) correctly with a 92.7%
sensitivity on a leave-one-out cross validation method (Table 4).

[Fig. 5d], and the loading for only this component is shown [Fig. 5c].
Many of the spectral diﬀerences recorded for bm-MSC versus St-SMCs
(TGF-β1) were also observed when ddSMC were compared bm-MSC
[Fig. 5c]. In addition to sharing these peaks, more peaks were observed
in PC1 that relate to nucleic acid at 813 cm− 1 and 1420 cm− 1; proteins
at 1031 cm− 1; and lipids at 1220–1250 cm− 1, 1420 cm− 1 and
1554 cm− 1.
In contrast, when the Raman spectra of ddSMC were compared to
St-SMC (TGF-β1), there were signiﬁcant similarities between both
spectra with sharp bands at the 1004 cm− 1, 1262 cm− 1, 1319 cm− 1,
1585 cm− 1 and 1662 cm− 1 [Fig. 5e]. Some diﬀerences were observed
at 788 cm− 1, 1319 cm− 1 and 1585 cm− 1, corresponding to nucleic
acid content, indicative of diﬀerences between the DNA/RNA content
of the St-SMCs (TGF-β1) and the ddSMCs [Fig. 5e]. Further diﬀerences
were observed in the region of 1262 cm− 1 attributable to the nucleic
acid guanine and amide III and at 1619 cm− 1 attributable to tyrosine or
tryptophan [Fig. 5e]. Raman spectra of ddSMCs were further compared
to St-Osteo and revealed signiﬁcant diﬀerences in the spectra of these
two populations, consistent primarily with the onset of mineralization
[data not shown]. Finally, PCA analysis of Raman spectra could not
directly separate the St-SMCs (TGF-β1) and ddSMC groups with 100%
accuracy [Fig. 5f]. However, classiﬁcation of both cell populations was

4. Discussion
Vibrational spectroscopy has shown great promise in functional
analysis of single cells and in label-free detection of diseases [14].
Raman micro-spectroscopy is normally performed in a point to point
mapping mode, and thus is considerably slower than FTIR in imaging
mode. Nevertheless, its higher spatial and spectral resolution favours it
for cellular and subcellular analysis, rather than large scale screening of
cell populations [16,33]. Multivariate statistical techniques such as
Principal Components Analysis (PCA) and Discriminant Analysis (DA)
have signiﬁcantly contributed to the development of diagnostic algorithms based on the information recovered in Raman and FTIR spectral
signatures. However, before vibrational spectroscopy can be fully implemented as a diagnostic platform, cross-validation with known immunohistochemical platforms for biomarker detection is required [34].
In this context, the current study has established for the ﬁrst time that
vibrational spectroscopy can discriminate undiﬀerentiated stem cells
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Fig. 4. (a) Representative phase contrast images of freshly isolated aortic SMCs and St-SMCs following TGF-β1 induced myogenic diﬀerentiation. (b) Immunocytochemical analysis of
SMA and Myh11 expression and (c) quantitative qRT-PCR of Myh11 mRNA levels in freshly isolated aortic SMCs, sub-cultured ddSMCs (passage 4) and St-SMCs following TGF-β1 induced
myogenic diﬀerentiation. (d) Mean FTIR spectra and (e) a 4-way scatter plot of the ﬁrst two principal components after PCA of bm-MSCs, ddSMCs, St-SMCs (TGF-β1) and St-Osteo. (f)
Mean Raman spectra and (g) a 4-way scatter plot of the ﬁrst two principal components after PCA for bm-MSCs, ddSMCs, St-SMCs (TGF-β1) and St-Osteo.

Table 3
Confusion matrix for PCA-LDA of FTIR spectral data showing the percentage classiﬁcation
for each cell type. Values on the diagonal represent those correctly identiﬁed, oﬀ-diagonal
values represent those incorrectly identiﬁed.

bm-MSC
St-Osteo
ddSMC
St-SMC

bm-MSC

St-Osteo

ddSMC

St-SMC

94
0
7
0

0
100
1
0

3
0
92
0

3
0
0
100

Table 4
Confusion matrix for PCA-LDA of Raman spectral data showing the percentage classiﬁcation for each cell type. Values on the diagonal represent those correctly identiﬁed, oﬀdiagonal values represent those incorrectly identiﬁed.

bm-MSC
St-Osteo
ddSMC
St-SMC

bm-MSC

St-Osteo

ddSMC

St-SMC

100
0
0
0

0
100
0
0

0
0
89.7
7.3

0
0
10.3
92.7

represents a major hallmark of cardiovascular disease [3]. Recent
lineage tracing studies in mice and biomarker identiﬁcation in human
vessels have provided compelling evidence that stem cell-derived
myogenic progeny (either directly or via endothelial-mesenchymaltransition) in addition to de-diﬀerentiated SMCs may be responsible for
neointimal formation [4,7,9,36]. Hence the ability to discriminate dediﬀerentiated SMC from undiﬀerentiated stem cells and their myogenic
and osteogenic progeny within the vessel wall and map their respective

from their myogenic and osteogenic progeny in vitro following validation using conventional genetic, biochemical and histological analyses.
While several studies have conﬁrmed the accuracy of Raman spectroscopy in various biological tissues such as the cervical lesions, gastric
tissues, colon, thyroid, larynx, skin, bladder amongst others [14], data
on the interrogation of vascular tissue for early signs of disease have
been limited [35]. The accumulation of neointimal SMC-like cells
within the vessel wall leading to the obstruction of blood ﬂow
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Fig. 5. (a) Mean Raman spectra and the loadings corresponding to the ﬁrst two principal components for bm-MSC and the St-SMCs-TGF-β1 following myogenic diﬀerentiation. Signiﬁcant
peaks in the loadings of PC1 and PC2 are highlighted and (b) corresponding scatter plot for the ﬁrst two principle components for bm-MSC and the St-SMCs-TGF-β1. Mean Raman spectra
and the loadings of the ﬁrst principle component and corresponding scatter plots for (c, d) bm-MSC versus ddSMCs and (e, f) ddSMCs versus St-SMC. For (c) and (d), only the ﬁrst loadings
are shown, corresponding only to PC1, since separation is found in this component alone.

type I receptor, ALK5], that results in phosphorylation-dependent activation of Smads 2 and 3 that subsequently complex with Smad4 and
translocate to the nucleus where they stimulate myogenic gene expression [40]. Similarly, Jag-1 binds to speciﬁc Notch receptors on the
plasma membrane that, once cleaved, act as transcriptional activators
of myogenic diﬀerentiation [41], including activation of the SMA promoter [42]. Both of these stimuli promoted myogenic diﬀerentiation of
bm-MSCs in vitro by inducing speciﬁc epigenetic changes at the Myh11
promoter leading to Myh11 promoter transactivation, increased expression of transcript for SMC diﬀerentiation markers (Myh11 and
CNN1) concomitant with a signiﬁcant increase in the number of
Myh11+, SMA+ and CNN1+ positive cells. Interrogation of de-diﬀerentiated SMCs (ddSMCs), undiﬀerentiated bm-MSC and their myogenic
(St-SMCs) and osteogenic progeny (St-Osteo) by FTIR revealed signiﬁcant diﬀerences in their respective spectral signatures. Notably, the
spectra associated with cellular phospholipid content of myogenic
progeny decreased when compared to undiﬀerentiated bm-MSC
whereas there was a marked increase in levels of eCH2 symmetric and
eCH and eCH3 asymmetric stretching associated with proteins and lipids. This was in contrast to osteogenic diﬀerentiation where there was
a notable marked decrease in levels of eCH2 symmetric and eCH and
eCH3 asymmetric stretching. Furthermore, the similarity in the pattern
of FTIR spectral changes for both TGF-β1 and Jag-1 myogenic progeny
when compared to undiﬀerentiated bm-MSC suggests that these differences are independent of the inductive stimulus and were speciﬁcally

accumulation over time using label-free platforms represents an attractive diagnostic platform for vascular proliferative disease.
Our studies reveal for the ﬁrst time that FTIR detects speciﬁc alterations in the cellular proﬁle of nucleic acid, protein and lipid content
of bm-MSC when they progress towards a distinct myogenic phenotype
in vitro. Moreover, Raman further distinguished a discriminant alteration in the nuclear spectra for nucleic acid, protein and lipid proﬁles of
these cells. These data highlight the signiﬁcant screening potential of
FTIR and the more analytical potential of Raman at discriminating
undiﬀerentiated stem cells from de-diﬀerentiated SMCs and stem cellderived osteogenic and myogenic progeny. Notably, the feasibility of
using prototype devices including a laser-scanning ﬁbre endoscope
(SFE) to interrogate vascular structure in real-time in vivo and detect the
early signs of disease has been validated [35,37].
The potential of FTIR to screen cell populations and discriminate
undiﬀerentiated stem cells from their osteogenic progeny was ﬁrst established. In particular, analysis of the FTIR spectra clearly indicated
the onset of mineralization via the emergence of the feature at
1037 cm− 1 which is associated with carbonate groups in apatite
[38,39]. Interrogation of individual cell nuclei by Raman spectroscopy
further distinguished a discriminant alteration in phosphate content in
situ due to the pronounced peak at 960 cm− 1 [27] that facilitated
identiﬁcation of these cells from each other by PCA.
TGF-β1 is known to activate a heteromeric complex of two serine/
threonine kinase receptors [the type IITGF-β receptor (TβRII) and the
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clonogenic human stem cell would give rise to a more homogenous
“true” human MSC population that could serve to provide similar results and further validate vibrational spectroscopic for clinical applications. Vibrational spectroscopy for ex vivo analysis of various tissues
aﬀected by vascular diseases, including atherosclerotic plaque, vessel
wall remodelling and endothelial dysfunction has been performed [52]
[51]. The Raman spectral diﬀerences in remodelled vessels following
IMT originated mainly from the protein features within the main bands
at 1660 cm− 1 (amide I), 1244 cm− 1 (amide III), and at 1004 cm− 1
(phenylalanine). In the spectrum of normal intimal SMCs, major bands
due to amide I (1656 cm− 1), amide II (1556 cm− 1), and CH bending
(1457 cm− 1) vibrations of the proteins collagen and elastin have also
been reported [35,52,53]. In the spectrum of the intima of non-calciﬁed
atherosclerotic plaque, major bands due to both proteins and lipids are
also observed. The lipid bands at 1734 cm− 1, 1468 cm− 1, 1171 cm− 1
and 1058 cm− 1 were assigned to the C = O (ester) stretch, CH2 bend,
CeO (ester) stretch and CeO stretch, respectively [35]. Our current
study suggests that St-SMCs exhibit similar enhanced spectral intensities at peaks at 1004 cm− 1 1451 cm− 1 and 1662 cm− 1 when
compared to bm-MSCs and ddSMCs respectively, suggesting that these
peak intensities might represent a speciﬁc photonic signature for stem
cell myogenic progeny that could be exploited diagnostically. Furthermore, as vascular lesions are often calciﬁed [3], the ability to discriminate between St-Osteo and St-SMCs is also an advantage. Our data
suggests that both FTIR and Raman can detect diﬀerences between
myogenic and osteogenic progeny even when they are derived from the
same undiﬀerentiated stem cell.
In conclusion, vibrational spectroscopy was successfully applied to
the study of bm-MSCs before and after myogenic diﬀerentiation in vitro
to identify discrete spectral characteristics that could facilitate localisation and detection of myogenic diﬀerentiation of resident vascular
stem cell populations in vivo. The vasculature is unique in that it has a
well-deﬁned spatial morphology of cells either side and within the internal (IEL) and external elastic lamina (EEL) that could facilitate acquisition of label-free analysis of cell spectra with relative conﬁdence.
The initial step in the development of arteriosclerotic disease is IMT and
neointimal formation that facilitates the build-up of LDL (low density
lipoprotein) particles within the intimal layer of the vessel wall [54,55].
Interrogation of early atherosclerotic vessels in situ using vibrational
spectroscopy could discriminate the presence of stem cell-derived progeny not readily available in current diagnostic imaging techniques
such as IVUS, MRI, and angiography. Indeed, signiﬁcant progress has
already been made towards in vivo application of vibrational spectroscopy. Raman spectroscopy in particular, as an optical probe, lends itself naturally to endoscopic application and has recently been deployed
for intra-operative guidance of brain surgery [56] and endoscopic
gastrointestinal procedures [57]. A smart Raman needle probe has also
been developed and tested for potential in vivo and ex vivo use, capable
of measuring Raman molecular tissue signals in < 1–2 s down a hypodermic needle [58]. Because of its high sensitivity to water, there
have been relatively fewer in vivo applications of IR spectroscopy, although the recent emergence of high brightness, tunable Quantum
Cascade Lasers has opened the door towards their development [59].
This suggests that, with further development, FTIR could provide initial
selection of cells for interrogation before quantitative chemical and
morphological evaluation by Raman discriminates these cells within
vascular lesions in situ, such as the presence of stem cell derived myogenic or osteogenic progeny so that more targeted therapies against
these discrete phenotypes can be introduced. Finally, circulating vascular cells and progenitor cells shed from the vessel wall during IMT
and disease progression could be retrieved from blood and interrogated
for clinical evaluation using vibrational spectroscopy to provide a more
deﬁnitive tool for early diagnosis [60]. The ability to assess the accumulation of stem cell-derived progeny using label free platforms in situ
or the shedding of these progeny into the blood during disease progression may further facilitate interrogation of these phenotypes by

associated with a myogenic inductive stimulus and response. Several
previous studies have shown a general decrease in nucleic acids in
undiﬀerentiated cells compared to their progeny [43] while similar
changes in protein composition (e.g., α-helix structures) in stem cells
when compared to diﬀerentiated cells have been described [43,44].
More recently, FTIR spectra have been used to successfully discriminate
functional hepatocyte and chondrocyte progeny from undiﬀerentiated
stems cells [rat bone marrow [45] murine ESCs [46] (both hepatocytes), and hMSCs [47](chondrocytes)] based on similar kinds of
spectral diﬀerences. As stem cell-derived myogenic progeny and dediﬀerentiated SMC were also separated by PCA analysis of their corresponding FTIR spectra, these data collectively suggest that FTIR is a
reliable platform to screen and map undiﬀerentiated stem cell populations from their myogenic progeny. Indeed, because of the limit of
resolution, the longer wavelength of mid infrared radiation, coupled
with the use of multidetector arrays in the Fourier Transform mode,
render IR techniques very suitable for mapping larger cell populations
or tissue sections [16].
Raman spectroscopy of individual cell nuclei from undiﬀerentiated
bm-MSC, their myogenic progeny (St-SMC-TGF-β1) and ddSMCs further
deﬁned discrete spectral shifts in these cell populations and quantitatively provided reliable estimates of in situ protein, nucleic acids and
lipid content of bm-MSCs before and after myogenic and osteogenic
diﬀerentiation. Nine distinct wavenumber bands within the ﬁngerprint
region 600–1800 cm− 1 were recorded that correspond to broad biochemical groupings [23,30,48]. Analysis of the spectra revealed signiﬁcant diﬀerences that facilitated further discrimination of these cell
populations by PCA. Notably, when compared to ddSMC, undiﬀerentiated bm-MSC had higher peaks at 785–788 cm− 1 and
1585 cm− 1 which are attributable to nucleic acid content. Similar
spectral diﬀerences were also observed at 785–788 cm− 1 for St-SMC.
This is not surprising, as stem cells are known to have a higher nucleic
acid content than diﬀerentiated cells [49,50]. The peak at 1262 cm− 1
that corresponds to nucleic acid and lipid content has also been associated with collagen [51] and is understandably higher in the ddSMC
when compared to bm-MSC. Other notable diﬀerences for St-SMC appear at 1319 cm− 1 and 1341 cm-1 and are associated with lipids, nucleic acids and proteins in addition to a higher peak at 1585 cm− 1
which corresponds to nucleic acids.
Importantly, there was a clear separation observed across the ﬁrst
principle component for bm-MSCs and St-SMCs and for bm-MSC and
ddSMCs by FTIR suggesting that these cell populations are clearly distinct. However, interrogation by Raman across the ﬁrst principle
component failed to separate these populations with 100% accuracy.
This is not unexpected since FTIR datasets are from whole cell spectra
while Raman spectra were generated exclusively from the cell nucleus.
The spectral diﬀerences within the cytoplasm may be more pronounced
as these cells begin to fate towards a myogenic lineage but still retain
signiﬁcant diﬀerences within their cytoplasmic content. It is also clear
that signiﬁcant epigenetic and genetic changes occur early within the
nucleus of bm-MSC as they undergo myogenic diﬀerentiation [28] and
these speciﬁc changes shared the greatest similarity with the ddSMCs.
Furthermore, since ddSMCs may be primarily derived from resident
stem cells as they grow and expand at an increased rate in culture [4], it
is not surprising that the Raman spectral proﬁle for myogenic progeny
shared the greatest similarity with de-diﬀerentiated SMC cells. Although PCA analysis did not separate the St-SMCs (TGF-β1) and ddSMC
groups with 100% accuracy, classiﬁcation of both cell lines was eventually achieved using a combination of PCA and LDA suggesting that
there are also important diﬀerences, despite these similarities.
A primary limitation of the current study is that the bm-MSC population were of rodent origin, heterogeneous in nature and expanded
in culture media that is diﬀerent from protocols required for pre-clinical
and clinical studies. Moreover, spectral measurements were taken with
cell cultures, rather than being obtained from an intact vessel in situ.
Culturing the progeny of a single CFU or phenotype-isolated single
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their discrete spectroscopic signatures using liquid biopsies and microﬂuidic platforms.
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